Eisai Inc.
Clinical trials sponsored by Eisai Inc., explained in plain language.
A pharmaceutical company focused on neurology and oncology, subsidiary of Eisai Co., Ltd.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
Can a new drug play nice with common medicines? a trial investigates
Knowledge-focused Not yet recruitingThis early-phase trial in healthy adults asks whether the experimental oral drug E2086 changes how the body processes several common medications, including an antifungal, a seizure drug, a sedative, a cough suppressant, an antidepressant, and birth control pills. Participants rec…
Phase: PHASE1 • Sponsor: Eisai Inc. • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
Mining medical claims: a smarter way to spot Alzheimer's complications?
Knowledge-focused Not yet recruitingThis study looks at whether insurance claims data can be used to reliably identify two serious complications in people with Alzheimer's disease: brain hemorrhages larger than 1 cm and new-onset seizures. Researchers will analyze records from 600 Alzheimer's patients, linking insu…
Sponsor: Eisai Inc. • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC